Sangamo Bankruptcy (SGMOQ)
Sangamo Therapeutics’ Chapter 11 asset sales leave common equity tied to $100 million in PTC Fabry therapy approval milestones and a…
OTC
Sangamo Therapeutics, INC
SGMO
1 article
$66M Market cap · 2026-08-31
OTC
SGMO
1 article
$66M Market cap · 2026-08-31
Sangamo Therapeutics’ Chapter 11 asset sales leave common equity tied to $100 million in PTC Fabry therapy approval milestones and a…